Innovation in Head & Neck Cancers!!! Dr. Mark Newman, CSO, GeoVax

episode

BioTech Nation ... with Dr. Moira Gunn not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Bears aren't ruling out Caleb Williams against Eagles, but will he play? (Hour 1) 41 min · 22 Sep 2026 · Rahimi & Grote Show

Week 3 Waivers + Someone to Blame - Fantasy Football Podcast for 9/22 52 min · 22 Sep 2026 · Fantasy Footballers - Fantasy Football Podcast

First Date Follow Up: She Thought Their Date Was Perfect… Until He Found Out She Was MARRIED! 16 min · 22 Sep 2026 · First Date Follow Up - The Jubal Show

Neville Gallimore talks Bears' 9-3 loss to Vikings, Caleb Williams' injury 18 min · 22 Sep 2026 · Rahimi & Grote Show

TUES PT 2: Should Bobby Have Said This During An Interview? + Lindsay Clancy’s Ex-Husband Bad Move + Disaster With 600 Pound Studio Delivery! 1h 13m · 22 Sep 2026 · The Bobby Bones Show

Bears aren't ruling out Caleb Williams against Eagles, but will he play? 11 min · 22 Sep 2026 · Rahimi & Grote Show

Report any issue

Source

Recorded09 Aug 2023

Publisherfeeds.transistor.fm ↗

Handlerec:13349850

Show notes

In this week's BioTech Nation, we discuss Geovax, a company working on a novel approach to treat head and neck cancers, which are often difficult to treat after standard options have been exhausted. Geovax is developing A2 component therapy, using an enzyme delivered directly to the tumor by a needle injection, followed by an infusion of an inactive form of a chemotherapeutic drug, which becomes toxic to the tumors when processed by the enzyme. The treatment aims to localize the effects, reduce side effects, and potentially activate the immune system to target other tumor cells in the body. Phase two trials are underway, with promising results so far.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in